Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1739571 | 1.00 | CYP3A4 (0.62) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| SCHEMBL217047 | 1.00 | CYP3A4 (0.62) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL31545549 | 0.99 | CYP3A4 (0.61) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| SCHEMBL31166209 | 0.88 | ALDH1A1 (0.48) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| SCHEMBL5305466 | 0.88 | ALDH1A1 (0.48) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| Tenamfetamine SCHEMBL9102083 | 0.83 | TAAR1 (0.57) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| SCHEMBL2350405 | 0.83 | CYP3A4 (0.59) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| SCHEMBL29827277 | 0.83 | CYP3A4 (0.59) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 | |
| SCHEMBL9781426 | 0.81 | CYP3A4 (0.69) | CYP3A4ALDH1A1SMN1; SMN2MEN1KMT2A | |
| Tenamfetamine SCHEMBL9102090 | 0.80 | SLC6A4 (0.53) | CYP3A4ALDH1A1SMN1; SMN2TAAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12303564-B2 | Composite chitosan-tannin-active agent compositions and methods of making and using same | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-05-20 | — | — | US | disclosed |
| WO-2024261775-A1 | A DRUG-ANTAGONIST COMBINATION DOSAGE FORM | PATEL JAYENDRAKUMAR DASHARATHLAL (IN) | 2024-12-26 | — | — | WO | disclosed |
| US-20220296720-A1 | COMPOSITE CHITOSAN-TANNIN-ACTIVE AGENT COMPOSITIONS AND METHODS OF MAKING AND USING SAME | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296720-A1 | COMPOSITE CHITOSAN-TANNIN-ACTIVE AGENT COMPOSITIONS AND METHODS OF MAKING AND USING SAME | TTPA, CHIA, CHIT1 | CYP3A4 4383/4885ALDH1A1 3850/4885SMN1; SMN2 2943/4885 |
| US-12303564-B2 | Composite chitosan-tannin-active agent compositions and methods of making and using same | TTPA, CHIA, CHIT1 | CYP3A4 4383/4885ALDH1A1 3850/4885SMN1; SMN2 2943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.